| Literature DB >> 29444771 |
Thibault Fiolet1, Bernard Srour2, Laury Sellem1, Emmanuelle Kesse-Guyot1, Benjamin Allès1, Caroline Méjean3, Mélanie Deschasaux1, Philippine Fassier1, Paule Latino-Martel1, Marie Beslay1, Serge Hercberg1,4, Céline Lavalette1, Carlos A Monteiro5, Chantal Julia1,4, Mathilde Touvier1.
Abstract
OBJECTIVE: To assess the prospective associations between consumption of ultra-processed food and risk of cancer.Entities:
Mesh:
Year: 2018 PMID: 29444771 PMCID: PMC5811844 DOI: 10.1136/bmj.k322
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Baseline characteristics of study population according to sex specific quarters of ultra-processed food consumption (n=104 980), NutriNet-Santé cohort, France, 2009-17*. Values are numbers (percentages) unless stated otherwise
| Characteristics | All participants | Quarters of ultra-processed food consumption | P for trend | |||
|---|---|---|---|---|---|---|
| 1 (n=26 244) | 2 (n=26 245) | 3 (n=26 246) | 4 (n=26 245) | |||
| Mean (SD) age, years | 42.8 (14.8) | 47.9 (13.5) | 45.0 (14.0) | 42.0 (14.4) | 36.5 (13.6) | <0.001 |
| Female sex | 82 159 (78.3) | 20 539 (78.3) | 20 540 (78.3) | 20 541 (78.3) | 20 542 (78.3) | – |
| Mean (SD) height, cm | 166.8 (8.1) | 166.3 (8.0) | 166.7 (8.0) | 167.0 (8.1) | 167.3 (8.2) | <0.001 |
| Mean (SD) body mass index | 23.8 (4.6) | 23.8 (4.3) | 23.8 (4.4) | 23.8 (4.5) | 23.8 (5.0) | 0.9 |
| Family history of cancer | 35 668 (34.0) | 10 542 (40.2) | 9624 (36.7) | 8625 (32.9) | 6877 (26.2) | <0.001 |
| Higher education: | 0.01 | |||||
| No | 19 357 (18.4) | 5154 (19.6) | 4961 (18.9) | 4637 (17.7) | 4605 (17.6) | |
| Yes, <2 years | 18 076 (17.2) | 3938 (15.0) | 4091 (15.6) | 4426 (16.9) | 5621 (21.4) | |
| Yes, ≥2 years | 67 547 (64.3) | 17 152 (65.4) | 17 193 (65.5) | 17 183 (65.5) | 16 019 (61.0) | |
| Smoking status: | <0.001 | |||||
| Current | 17 763 (16.9) | 4127 (15.7) | 4065 (15.5) | 4266 (16.3) | 5305 (20.2) | |
| Never/former | 87 217 (83.1) | 22 117 (84.3) | 22 180 (84.5) | 21 980 (83.8) | 20 940 (79.8) | |
| IPAQ physical activity level: | <0.001 | |||||
| High | 29 603 (28.2) | 8753 (33.4) | 7762 (29.6) | 6983 (26.6) | 6105 (23.3) | |
| Moderate | 38 874 (37.0) | 9620 (36.7) | 9953 (37.9) | 9814 (37.4) | 9487 (36.2) | |
| Low | 21 888 (20.9) | 4407 (16.8) | 5152 (19.6) | 5839 (22.3) | 6490 (24.7) | |
| Mean (SD) energy intake without alcohol, kcal/d | 1879.0 (473.7) | 1810.6 (454.1) | 1881.1 (457.7) | 1908.5 (472.3) | 1915.8 (501.8) | <0.001 |
| Mean (SD) alcohol intake, g/d | 7.8 (11.9) | 9.3 (13.3) | 8.5 (11.9) | 7.5 (11.3) | 5.9 (10.5) | <0.001 |
| Mean (SD) total lipid intake, g/d | 80.5 (25.5) | 76.0 (24.3) | 80.3 (24.4) | 82.1 (25.3) | 83.4 (27.3) | <0.001 |
| Mean (SD) carbohydrate intake, g/d | 195.4 (57.9) | 184.6 (57.8) | 193.9 (55.3) | 199.3 (56.6) | 203.6 (60.2) | <0.001 |
| Mean (SD) sodium intake, mg/d | 2700.1 (893.1) | 2589.3 (881.6) | 2731.8 (871.0) | 2761.9 (884.1) | 2717.7 (925.0) | <0.001 |
| Mean (SD) No of children | 1.3 (1.2) | 1.6 (1.2) | 1.4 (1.2) | 1.3 (1.2) | 1.0 (1.2) | <0.001 |
| Menopausal status: | <0.001 | |||||
| Premenopausal | 57 408 (69.9) | 11 797 (57.4) | 13 497 (65.7) | 14 961 (72.8) | 17 153 (83.5) | |
| Perimenopausal | 4282 (5.2) | 1471 (7.2) | 1148 (5.6) | 997 (4.9) | 666 (3.2) | |
| Postmenopausal | 20 469 (24.9) | 7271 (35.4) | 5895 (28.7) | 4582 (22.3) | 2721 (13.3) | |
| Use of hormonal treatment for menopause | 4324 (5.3) | 1602 (7.8) | 1242 (6.1) | 932 (4.5) | 548 (2.7) | <0.001 |
| Oral contraception | 23 073 (22.0) | 3779 (14.4) | 4990 (19.0) | 6209 (23.7) | 8095 (30.8) | <0.001 |
| Mean (SD) ultra-processed food, % | 18.7 (10.1) | 8.5 (2.5) | 14.3 (1.4) | 19.8 (1.9) | 32.3 (9.8) | – |
IPAQ=International Physical Activity Questionnaire.
For all covariates except physical activity, a very low proportion of values were missing (0-5%); these were replaced by modal value in study population: “≥2 years of higher education” for educational level, 0 for No of biological children, 22.9 for body mass index, 166 cm for height, and non-smoker for smoking status.
Sex specific quarters of proportion of ultra-processed food intake in total quantity of food consumed; sex specific cut-offs for quarters of ultra-processed proportions were 11.8%, 16.8%, and 23.3% in men and 11.8%, 16.8%, and 23.4% in women.
P value for comparison between sex specific quarters of ultra-processed food consumption, by Fisher test or χ2 test where appropriate.
Among first degree relatives.
Available for 90 365 participants; participants were categorised into “high,” “moderate,” and “low” categories according to IPAQ guidelines.35
Among women.
Fig 1Relative contribution of each food group to ultra-processed food consumption in diet
Associations between ultra-processed food intake and risk of overall, prostate, colorectal, and breast cancer, from multivariable Cox proportional hazard models*, NutriNet-Santé cohort, France, 2009-17 (n=104 980)
| Proportion of ultra-processed food intake in the diet | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Continuous | Sex specific quarters | |||||||||
| 1 | 2 | 3 | 4 | P for trend | ||||||
| HR (95% CI) | P for trend | HR | HR (95% CI) | HR (95% CI) | HR (95% CI) | |||||
|
| ||||||||||
| No of cases/non-cases | 2228/102 752 | 712/25 532 | 607/25 638 | 541/25 705 | 368/25 877 | |||||
| Model 1 | 1.12 (1.06 to 1.18) | <0.001 | 1 | 0.99 (0.89 to 1.11) | 1.10 (0.99 to 1.24) | 1.21 (1.06 to 1.38) | 0.002 | |||
| Model 2 | 1.12 (1.07 to 1.18) | <0.001 | 1 | 1.00 (0.90 to 1.11) | 1.11 (0.99 to 1.25) | 1.23 (1.08 to 1.40) | 0.001 | |||
| Model 3 | 1.12 (1.06 to 1.18) | <0.001 | 1 | 0.99 (0.89 to 1.11) | 1.01 (0.98 to 1.23) | 1.21 (1.06 to 1.38) | 0.002 | |||
| Model 4 | 1.13 (1.07 to 1.18) | <0.001 | 1 | 1.00 (0.90 to 1.11) | 1.11 (0.99 to 1.24) | 1.23 (1.08 to 1.40) | 0.001 | |||
|
| ||||||||||
| No of cases/non-cases | 281/22 540 | 96/5609 | 96/5609 | 59/5647 | 30/5675 | |||||
| Model 1 | 0.98 (0.83 to 1.16) | 0.8 | 1 | 1.18 (0.89 to 1.57) | 0.95 (0.69 to 1.32) | 0.93 (0.61 to 1.40) | 0.6 | |||
| Model 2 | 0.98 (0.83 to 1.16) | 0.8 | 1 | 1.18 (0.89 to 1.57) | 0.95 (0.69 to 1.32) | 0.93 (0.61 to 1.40) | 0.6 | |||
| Model 3 | 0.98 (0.83 to 1.15) | 0.8 | 1 | 1.18 (0.89 to 1.56) | 0.95 (0.68 to 1.31) | 0.92 (0.61 to 1.39) | 0.6 | |||
| Model 4 | 0.98 (0.83 to 1.16) | 0.8 | 1 | 1.18 (0.89 to 1.57) | 0.95 (0.68 to 1.32) | 0.93 (0.61 to 1.40) | 0.6 | |||
|
| ||||||||||
| No of cases/non-cases | 153/104 827 | 48/26 196 | 43/26 202 | 36/26 210 | 26/26 219 | |||||
| Model 1 | 1.13 (0.92 to 1.38) | 0.2 | 1 | 1.10 (0.72 to 1.66) | 1.17 (0.76 to 1.81) | 1.49 (0.92 to 2.43) | 0.1 | |||
| Model 2 | 1.16 (0.95 to 1.42) | 0.1 | 1 | 1.12 (0.74 to 1.70) | 1.22 (0.79 to 1.90) | 1.59 (0.97 to 2.60) | 0.07 | |||
| Model 3 | 1.13 (0.92 to 1.38) | 0.2 | 1 | 1.09 (0.92 to 1.38) | 1.16 (0.75 to 1.80) | 1.48 (0.91 to 2.41) | 0.1 | |||
| Model 4 | 1.16 (0.95 to 1.42) | 0.1 | 1 | 1.12 (0.74 to 1.70) | 1.22 (0.79 to 1.89) | 1.23 (1.08 to 1.40) | 0.07 | |||
|
| ||||||||||
| No of cases/non-cases | 739/81 420 | 247/20 292 | 202/20 338 | 179/20 361 | 111/20 429 | |||||
| Model 1 | 1.11 (1.02 to 1.22) | 0.02 | 1 | 0.97 (0.81 to 1.17) | 1.10 (0.90 to 1.34) | 1.14 (0.91 to 1.44) | 0.2 | |||
| Model 2 | 1.11 (1.01 to 1.21) | 0.03 | 1 | 0.96 (0.80 to 1.16) | 1.09 (0.89 to 1.32) | 1.12 (0.89 to 1.42) | 0.2 | |||
| Model 3 | 1.11 (1.02 to 1.22) | 0.02 | 1 | 0.97 (0.80 to 1.17) | 1.09 (0.90 to 1.33) | 1.14 (0.91 to 1.44) | 0.2 | |||
| Model 4 | 1.11 (1.01 to 1.21) | 0.03 | 1 | 0.96 (0.80 to 1.16) | 1.08 (0.89 to 1.32) | 1.13 (0.89 to 1.42) | 0.2 | |||
|
| ||||||||||
| No of cases/non-cases | 264/57 151 | 90/14 263 | 70/14 284 | 55/14 299 | 49/14 305 | |||||
| Model 1 | 1.09 (0.95 to 1.25) | 0.2 | 1 | 0.91 (0.67 to 1.25) | 0.92 (0.65 to 1.29) | 1.30 (0.90 to 1.86) | 0.3 | |||
| Model 2 | 1.07 (0.93 to 1.23) | 0.4 | 1 | 0.90 (0.66 to 1.24) | 0.90 (0.64 to 1.27) | 1.25 (0.87 to 1.80) | 0.4 | |||
| Model 3 | 1.09 (0.95 to 1.26) | 0.2 | 1 | 0.91 (0.67 to 1.25) | 0.92 (0.66 to 1.30) | 1.30 (0.91 to 1.88) | 0.3 | |||
| Model 4 | 1.08 (0.94 to 1.24) | 0.3 | 1 | 0.91 (0.66 to 1.24) | 0.91 (0.64 to 1.28) | 1.27 (0.88 to 1.83) | 0.4 | |||
|
| ||||||||||
| No of cases/non-cases | 475/29 191 | 107/7309 | 128/7289 | 123/7294 | 117/7299 | |||||
| Model 1 | 1.13 (1.01 to 1.27) | 0.04 | 1 | 1.23 (0.95 to 1.60) | 1.28 (0.98 to 1.66) | 1.39 (1.07 to 1.82) | 0.02 | |||
| Model 2 | 1.13 (1.00 to 1.27) | 0.05 | 1 | 1.23 (0.95 to 1.60) | 1.27 (0.98 to 1.65) | 1.39 (1.05 to 1.81) | 0.02 | |||
| Model 3 | 1.13 (1.00 to 1.27) | 0.04 | 1 | 1.23 (0.95 to 1.59) | 1.27 (0.98 to 1.65) | 1.38 (1.06 to 1.81) | 0.02 | |||
| Model 4 | 1.13 (1.00 to 1.27) | 0.05 | 1 | 1.23 (0.95 to 1.59) | 1.27 (0.97 to 1.65) | 1.38 (1.05 to 1.81) | 0.02 | |||
HR=hazard ratio.
Model 1=multivariable Cox proportional hazard model adjusted for age (timescale), sex, energy intake without alcohol, number of 24 hour dietary records, smoking status, educational level, physical activity, height, body mass index, alcohol intake, and family history of cancers; breast cancer models were additionally adjusted for menopausal status, hormonal treatment for menopause, oral contraception, and number of children. Model 2=model 1 plus intakes of lipids, sodium, and carbohydrates. Model 3=model 1 plus Western dietary pattern (derived by factor analysis). Model 4=model 1 plus intakes of lipids, sodium, and carbohydrates and Western dietary pattern (derived by factor analysis). Pearson correlation coefficients with Western dietary pattern were 0.5 for dietary lipids, 0.6 for sodium, and 0.40 for carbohydrates.
Hazard ratio for increase of 10% in proportion of ultra-processed food intake in diet.
Sex specific cut-offs for quarters of ultra-processed proportions were 11.8%, 16.8%, and 23.3% in men and 11.8%, 16.8%, and 23.4% in women. In premenopausal women, cut-offs were 12.8%, 18.1%, and 25.0%. In postmenopausal women, cut-offs were 10.1%, 14.3%, and 19.5%.
Fig 2Cumulative cancer incidence (overall cancer risk) according to quarters of proportion of ultra-processed food in diet